Novelion Therapeutics
Other - , ,
Novelion Therapeutics Employees
Novelion Therapeutics Details
Novelion Therapeutics is a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases. Novelion has a diversified commercial portfolio through its indirect subsidiary, Aegerion Pharmaceuticals, Inc. (Aegerion), which includes MYALEPT® and JUXTAPID®, and is also developing zuretinol acetate for the potential treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company seeks to advance its portfolio of rare disease therapies by investing in science and clinical development.
Website:
novelion.com
Employees:
250 - 499
HQ:
N/A
Location:
, ,
Revenue:
Not Available
Novelion Therapeutics Technologies
Email Providers
Outlook
Customer Relationship Management
Salesforce
Hosting
Amazon AWS